Imagen de Portada

Advancing Probiotic Intervention Studies in Preterm Infants / Reply

Guardado en:
Publicado en:JAMA Pediatrics vol. 179, no. 2 (Feb 2025), p. 220
Autor principal: Guo, Xiaolong, BM
Otros Autores: Wang, Yongfeng, MD, Härtel, Christoph, MD, Haiß, Annette, PhD, Gehring, Stephan, MD
Publicado:
American Medical Association
Materias:
Neonates
Probiotics
Population studies
Infants
Microbiomes
Drug resistance
Dysbacteriosis
Acceso en línea:Citation/Abstract
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Resumen:Hartel and colleagues appreciate the letter by Guo and Wang reflecting the findings of their recent Bifidobacterium and Lactobacillus Probioticsand Gut Dysbiosis in Preterm Infants (PRIMAL) Randomized Clinical Trial. The single-country focus of the PRIMAL approach to study the effect of multistrain probiotics on the prevalence of drug-resistant organisms and microbiome patterns limits the universality of findings. However, it should be emphasized that our study population is representative for Germany and characterized by diversity in ethnical background, culture, dietary habits, and lifestyle of families.
ISSN:2168-6203
2168-6211
0096-6914
1072-4710
0096-8994
0002-922X
DOI:10.1001/jamapediatrics.2024.5301
Fuente:Healthcare Administration Database